Romaco Resourcs (METC) Coverage Initiated by Analysts at BMO Capital Markets

Romaco Resourcs (METC) Coverage Initiated by Analysts at BMO Capital Markets

A number of other research firms have also weighed in on METC. Credit Suisse Group began coverage on shares of Romaco Resourcs in a report on Tuesday. They set an outperform rating and a $14.00 target price for the company. Jefferies Group LLC began coverage on shares of Romaco Resourcs in a report on Tuesday. They set a buy rating and a $16.00 target price for the company. Five analysts have rated the stock with a buy rating, The stock currently has an average rating of Buy and a consensus…

TPG Specialty Lending Inc (TSLX) Downgraded by Zacks Investment Research to “Hold”

TPG Specialty Lending Inc (TSLX) Downgraded by Zacks Investment Research to “Hold”

According to Zacks, “TPG Specialty Lending, Inc. is a specialty finance company. It is focused on providing fully-underwritten capital solutions to middle market companies. The Company specializes in standalone first-lien loans, standalone second-lien loans, mezzanine loans, unitranche loans. TPG Specialty Lending, Inc. is based in Fort Worth, Texas. “ Zacks Investment Research cut shares of TPG Specialty Lending Inc (NYSE:TSLX) from a buy rating to a hold rating in a research report released on Tuesday morning. TSLX has been the subject of a number of other research reports. JMP Securities…

Workday, Inc. (WDAY) Receives Overweight Rating from Mitsubishi UFJ Financial Group

Workday, Inc. (WDAY) Receives Overweight Rating from Mitsubishi UFJ Financial Group

A number of other equities research analysts have also recently issued reports on the stock. BTIG Research upped their price objective on shares of Workday from $88.00 to $97.00 and gave the stock a buy rating in a report on Tuesday. Citigroup Inc. cut shares of Workday from a neutral rating to a sell rating and upped their price objective for the stock from $73.00 to $77.00 in a report on Tuesday. They noted that the move was a valuation call. Evercore ISI cut shares of Workday from a buy…

Alexion Pharmaceuticals, Inc. (ALXN) Now Covered by Analysts at Nomura

Alexion Pharmaceuticals, Inc. (ALXN) Now Covered by Analysts at Nomura

ALXN has been the topic of a number of other reports. Cowen and Company restated a “buy” rating and set a $180.00 price target on shares of Alexion Pharmaceuticals in a research note on Monday, December 12th. Vetr raised Alexion Pharmaceuticals from a “hold” rating to a “buy” rating and set a $145.34 price objective on the stock in a research report on Wednesday, January 11th. FBR & Co reaffirmed a “hold” rating on shares of Alexion Pharmaceuticals in a research report on Monday, November 14th. Leerink Swann set a…

Jazz Pharmaceuticals PLC (JAZZ) Given a $170.00 Price Target at Leerink Swann

Jazz Pharmaceuticals PLC (JAZZ) Given a $170.00 Price Target at Leerink Swann

A number of other research firms have also weighed in on JAZZ. Deutsche Bank AG set a $148.00 price target on shares of Jazz Pharmaceuticals PLC and gave the company a “buy” rating in a report on Wednesday, February 8th. BMO Capital Markets reaffirmed an “outperform” rating and set a $192.00 price target on shares of Jazz Pharmaceuticals PLC in a report on Thursday, January 12th. Goldman Sachs Group Inc reaffirmed a “buy” rating and set a $170.00 price target on shares of Jazz Pharmaceuticals PLC in a report on…

Proofpoint, Inc. (PFPT) EVP David Knight Sells 23,000 Shares

Proofpoint, Inc. (PFPT) EVP David Knight Sells 23,000 Shares

David Knight also recently made the following trade(s): Proofpoint, Inc. (NASDAQ:PFPT) EVP David Knight sold 23,000 shares of the business’s stock in a transaction on Friday, February 24th. The stock was sold at an average price of $80.07, for a total value of $1,841,610.00. Following the completion of the sale, the executive vice president now directly owns 33,052 shares in the company, valued at $2,646,473.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Shares of Proofpoint, Inc. (NASDAQ:PFPT)…

La Jolla Pharmaceutical Company (LJPC) Receives “Buy” Rating from J P Morgan Chase & Co

La Jolla Pharmaceutical Company (LJPC) Receives “Buy” Rating from J P Morgan Chase & Co

LJPC has been the subject of several other reports. SunTrust Banks, Inc. restated a buy rating and set a $57.00 target price (up from $38.00) on shares of La Jolla Pharmaceutical Company in a report on Monday. Zacks Investment Research upgraded La Jolla Pharmaceutical Company from a sell rating to a hold rating in a report on Tuesday, January 17th. Chardan Capital restated a top pick rating and set a $75.00 target price on shares of La Jolla Pharmaceutical Company in a report on Tuesday, January 24th. Finally, Jefferies Group…

Centurylink Inc (CTL) Coverage Initiated by Analysts at Moffett Nathanson

Centurylink Inc (CTL) Coverage Initiated by Analysts at Moffett Nathanson

CTL has been the topic of several other reports. Jefferies Group LLC reaffirmed a sell rating and issued a $20.00 price target (down from $24.00) on shares of Centurylink in a report on Tuesday, November 1st. Vetr raised shares of Centurylink from a buy rating to a strong-buy rating and set a $27.84 price target on the stock in a report on Wednesday, February 8th. SunTrust Banks, Inc. began coverage on shares of Centurylink in a report on Monday, December 12th. They issued a hold rating and a $27.00 price…

Adobe Systems Incorporated (ADBE) Receives New Coverage from Analysts at Robert W. Baird

Adobe Systems Incorporated (ADBE) Receives New Coverage from Analysts at Robert W. Baird

Several other analysts have also recently weighed in on ADBE. Credit Suisse Group reissued a neutral rating and set a $105.00 price target on shares of Adobe Systems in a report on Monday, October 31st. Wunderlich reissued a hold rating and set a $115.00 price target (up from $99.00) on shares of Adobe Systems in a report on Thursday, November 3rd. Pacific Crest reissued a buy rating and set a $122.00 price target on shares of Adobe Systems in a report on Thursday, November 3rd. Deutsche Bank AG reissued a…

Biomerica, Inc. (BMRA) President Sells $36,900.00 in Stock

Biomerica, Inc. (BMRA) President Sells $36,900.00 in Stock

Shares of Biomerica, Inc. (OTCMKTS:BMRA) traded up 2.44% during midday trading on Wednesday, reaching $2.52. 19,912 shares of the company traded hands. The company’s 50 day moving average is $2.53 and its 200-day moving average is $2.54. The stock’s market capitalization is $21.32 million. Biomerica, Inc. has a 12 month low of $1.10 and a 12 month high of $3.38. Biomerica, Inc. (OTCMKTS:BMRA) President Francis E. Capitanio sold 15,000 shares of the business’s stock in a transaction that occurred on Monday, February 27th. The shares were sold at an average…